The Sclerotherapy Market was valued at USD 1.13 billion in 2023 and is expected to witness steady growth, reaching USD 1.68 billion by 2032, registering a CAGR of 4.50% during the forecast period from 2024 to 2032. The increasing prevalence of varicose veins, spider veins, and other venous disorders, coupled with a growing preference...